Dilated Cardiomyopathy (DCM) is a critical cardiovascular condition marked by the enlargement of the heart's chambers, particularly the left ventricle. This pathology results in the weakening of the heart muscle, compromising its ability to pump blood effectively. The dilation and diminished pumping function characterize the heart's struggle in maintaining its normal operation. Various factors contribute to the development of DCM, such as genetic predisposition, viral infections, certain medications, and exposure to toxins. Recognizable symptoms often encompass fatigue, shortness of breath, leg swelling, and irregular heartbeat. Identification of DCM in its early stages is crucial for effectively managing the condition and preventing potential complications. Diagnostic measures typically involve a combination of medical history assessments, physical examinations, and advanced cardiac imaging techniques. Treatment strategies for DCM are multifaceted and may involve medications to enhance heart function, mitigate symptoms, and manage underlying causes.
Title : Complete heart block and persistent left SVC: A pacing challenge after AV canal repair
Moataz Taha Mahmoud, Madinah Cardiac Center, Saudi Arabia
Title : Chemical detergent anionic surfactant-inducing dry cardiomyopathy (Yasser's cardiomyopathy) with parallel pupils/CXR phenomenon (Yasser's ophthalmic phenomenon), up-down Yasser's alternance, S1Q3 flat T3 pattern - Dramatic response to honey with possible cardiac regeneration - A case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt
Title : Stabilization of molecular structures in red blood cell membrane by magnetite nanoparticles (ICNB) during storage
Andrey Belousov, Laboratory of Applied Nanotechnology of Belousov and Kharkiv National Medical University, Ukraine